Kathleen C Ellwood

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint How the US Food and Drug Administration evaluates the scientific evidence for health claims
    Kathleen C Ellwood
    Center for Food Safety and Applied Nutrition, Office of Nutrition, Labeling, and Dietary Supplements, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 68:114-21. 2010
  2. ncbi request reprint Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, Food and Drug Administration, College Park, MD, USA
    Am J Clin Nutr 84:971-4. 2006
  3. doi request reprint Qualified health claims for calcium and colorectal, breast, and prostate cancers: The U.S. Food and Drug Administration's evidence-based review
    Claudine J Kavanaugh
    Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Cancer 61:157-64. 2009
  4. ncbi request reprint The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer
    Claudine J Kavanaugh
    Rd, Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    J Natl Cancer Inst 99:1074-85. 2007
  5. ncbi request reprint Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 65:78-87. 2007
  6. ncbi request reprint Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 64:357-63. 2006

Detail Information

Publications6

  1. doi request reprint How the US Food and Drug Administration evaluates the scientific evidence for health claims
    Kathleen C Ellwood
    Center for Food Safety and Applied Nutrition, Office of Nutrition, Labeling, and Dietary Supplements, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 68:114-21. 2010
    ..quot; The process used by the FDA to review the scientific evidence for health claims and qualified health claims are described in this article...
  2. ncbi request reprint Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, Food and Drug Administration, College Park, MD, USA
    Am J Clin Nutr 84:971-4. 2006
    ..On the basis of this evidence-based review, the FDA concluded that no credible evidence exists for a health claim about the intake of lutein or zeaxanthin (or both) and the risk of age-related macular degeneration or cataracts...
  3. doi request reprint Qualified health claims for calcium and colorectal, breast, and prostate cancers: The U.S. Food and Drug Administration's evidence-based review
    Claudine J Kavanaugh
    Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Cancer 61:157-64. 2009
    ..FDA found no credible evidence to support health claims for calcium and a reduced risk of breast and prostate cancers. The agency did find limited evidence for the relationship between calcium intake and colorectal cancer risk...
  4. ncbi request reprint The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer
    Claudine J Kavanaugh
    Rd, Center for Food Safety and Applied Nutrition, U S Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    J Natl Cancer Inst 99:1074-85. 2007
    ..The FDA found very limited evidence to support an association between tomato consumption and reduced risks of prostate, ovarian, gastric, and pancreatic cancers...
  5. ncbi request reprint Supplemental calcium and risk reduction of hypertension, pregnancy-induced hypertension, and preeclampsia: an evidence-based review by the US Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, HFS 830, 5100 Paint Branch Parkway, College Park, MD 20740, USA
    Nutr Rev 65:78-87. 2007
    ....
  6. ncbi request reprint Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration
    Paula R Trumbo
    Division of Nutrition Programs and Labeling, US Food and Drug Administration, College Park, Maryland, USA
    Nutr Rev 64:357-63. 2006
    ..The agency concluded that the relationship between chromium picolinate intake and insulin resistance is highly uncertain...